This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Genocea Biosciences Future Growth
Future criteria checks 0/6
Key information
-19.8%
Earnings growth rate
-19.2%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | -162.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | N/A | -54 | N/A | N/A | 1 |
| 12/31/2022 | N/A | -51 | N/A | N/A | 1 |
| 3/31/2022 | 2 | -37 | -51 | -48 | N/A |
| 12/31/2021 | 2 | -33 | -49 | -45 | N/A |
| 9/30/2021 | 2 | -35 | -48 | -44 | N/A |
| 6/30/2021 | 0 | -36 | -45 | -41 | N/A |
| 3/31/2021 | 1 | -43 | -44 | -40 | N/A |
| 12/31/2020 | 1 | -44 | -44 | -42 | N/A |
| 9/30/2020 | 1 | -38 | -42 | -41 | N/A |
| 6/30/2020 | 1 | -41 | -45 | -44 | N/A |
| 3/31/2020 | N/A | -36 | -42 | -41 | N/A |
| 12/31/2019 | N/A | -39 | -39 | -38 | N/A |
| 9/30/2019 | N/A | -29 | -38 | -37 | N/A |
| 6/30/2019 | N/A | -30 | -37 | -36 | N/A |
| 3/31/2019 | N/A | -27 | -39 | -38 | N/A |
| 12/31/2018 | N/A | -28 | -41 | -41 | N/A |
| 9/30/2018 | N/A | -39 | -41 | -41 | N/A |
| 6/30/2018 | N/A | -48 | -44 | -43 | N/A |
| 3/31/2018 | N/A | -59 | -47 | -46 | N/A |
| 12/31/2017 | N/A | -57 | -49 | -48 | N/A |
| 9/30/2017 | N/A | -62 | -53 | -51 | N/A |
| 6/30/2017 | N/A | -58 | -52 | -50 | N/A |
| 3/31/2017 | N/A | -54 | -49 | -46 | N/A |
| 12/31/2016 | 0 | -50 | -44 | -42 | N/A |
| 9/30/2016 | 0 | -44 | -43 | -40 | N/A |
| 6/30/2016 | 1 | -41 | -41 | -38 | N/A |
| 3/31/2016 | 1 | -40 | -41 | -38 | N/A |
| 12/31/2015 | 1 | -42 | N/A | -38 | N/A |
| 9/30/2015 | 1 | -44 | N/A | -37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GBI1 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GBI1 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GBI1 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GBI1 is forecast to have no revenue next year.
High Growth Revenue: GBI1 is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GBI1's Return on Equity is forecast to be high in 3 years time